The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial
Open accessAbstract
Background: The subcutaneous (S) implantable cardioverter-defibrillator (ICD) is safe and effective for sudden cardiac death prevention. However, patients in previous S-ICD studies had fewer comorbidities, had less left ventricular dysfunction, and received more inappropriate shocks (IAS) than in typical transvenous ICD trials. The UNTOUCHED trial (Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction) was designed to evaluate the IAS rate in a more typical, contemporary ICD patient population implanted with the S-ICD using standardized programming and enhanced discrimination algorithms. Methods: Primary prevention patients with left ventricular ejection fraction ≤35% and no pacing indications were included. Generation 2 or 3 S-ICD devices were implanted and programmed with rate-based therapy delivery for rates ≥250 beats per minute and morphology discrimination for rates ≥200 and <250 beats per minute. Patients were followed for 18 months. The primary end point was the IAS-free rate compared with a 91.6% performance goal, derived from the results for the ICD-only patients in the MADIT-RIT study (Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy). Kaplan-Meier analyses were performed to evaluate event-free rates for IAS, all-cause shock, and complications. Multivariable proportional hazard analysis was performed to determine predictors of end points. Results: S-ICD implant was attempted in 1116 patients, and 1111 patients were included in postimplant follow-up analysis. The cohort had a mean age of 55.8±12.4 years, 25.6% were women, 23.4% were Black, 53.5% had ischemic heart disease, 87.7% had symptomatic heart failure, and the mean left ventricular ejection fraction was 26.4±5.8%. Eighteen-month freedom from IAS was 95.9% (lower confidence limit, 94.8%). Predictors of reduced incidence of IAS were implanting the most recent generation of device, using the 3-incision technique, no history of atrial fibrillation, and ischemic cause. The 18-month all-cause shock-free rate was 90.6% (lower confidence limit, 89.0%), meeting the prespecified performance goal of 85.8%. Conversion success rate for appropriate, discrete episodes was 98.4%. Complication-free rate at 18 months was 92.7%. Conclusions: This study demonstrates high efficacy and safety with contemporary S-ICD devices and programming despite the relatively high incidence of comorbidities in comparison with earlier S-ICD trials. The inappropriate shock rate (3.1% at 1 year) is the lowest reported for the S-ICD and lower than many transvenous ICD studies using contemporary programming to reduce IAS. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02433379.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412503 · Cited by 2,489
Cited by
Zeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,140
Self-citationEfficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator
Friedman, P., Murgatroyd, F., Boersma, L. V. A., Manlucu, J., O’Donnell, D., Knight, B. P., Clémenty, N., Leclercq, C., Amin, A., Merkely, B. P., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206485 · Cited by 255
Self-citationMedeiros, P., Santos, M., Arantes, C., Pereira, V. H., & Rocha, S. (2023) · Heart & Lung · doi:10.1016/j.hrtlng.2023.02.012 · Cited by 9
Metadata
- Authors
- Gold, M. R., Lambiase, P. D., El-Chami, M. F., Knops, R. E., Aasbo, J. D., Bongiorni, M. G., Russo, A. M., Deharo, J.-C., Burke, M. C., Dinerman, J., Barr, C. S., Shaik, N., Carter, N., Stoltz, T., Stein, K. M., Brisben, A. J., Boersma, L. V. A., Phelan, T., Al-Ameri, H., Albirini, A., Alimohammad, R., Arias, M., Badenco, N., Bertaux, G., Bhakta, D., Bindra, S., Blangy, H., Boveda, S., Brock, J., Busch, M., Calvo, N., Cassidy, C., Chauvin, M., Marzak, H., Chinitz, J., Ciuffo, A., Clancy, J., Crossen, K., De Filippo, P., Devecchi, F., Karanam, S., Doshi, R., Eckardt, L., Fedor, M., Freedman, R., Gehi, A., Goethals, P., Gosau, N., Gottlieb, C., Granrud, G., Greenstein, R., Hamdan, F., Hanon, S., Hassankhani, A., Henderson, R., Hohnloser, S., Huang, D., Irles, D., Kalahasty, G., Kazemian, P., Khairallah, F., Kim, B., Kim, E., Klein, C., Knight, B., Koide, N., Kuk, R., Leclercq, C., Lee, M., Lee, S.-C., Lenz, C., Lewis, N., Lewis, R., Mark, G., Marquie, C., McDonnell, K., Mckenzie, J., Merchant, F., Mobarek, S., Moccetti, T., Molin, F., Philliopon, F., Morani, G., Morin, D., Ng, G., Nsah, E., Panday, M., Pasquie, J.-L., Castellano Perez, N., Perez-Gil, F., Ptaszynski, P., Rajendra, A., Rhodes, T., Roberts, P., Rowe, S., Saba, S., Sagi, V., Sarter, B., Schoenhard, J., Schutzman, J., Scott, L., Segerson, N., Shakir, A., Smelley, M., Steffel, J., Sturdivant, J. L., Tabbal, G., Tendler, D., Theuns, D., Timmers, L., Trojan, M., Tsai, S., Upadhyay, G., Varkey, S., Viani, S., Weiner, S., Weiss, R., Wiggins, S., Wright, D., Zadeh, A., & Zitron, E.
- Venue
- Circulation
- Published
- 2021-01-05
- Volume
- 143
- Issue
- 1
- Pages
- 7-17
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3093256113
- Cited by
- 225
- References
- 3
- FWCI
- 18.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.